RESPONSES TO T-CELL RECEPTOR CD3 AND INTERLEUKIN-2 RECEPTOR STIMULATION ARE ALTERED IN T-CELLS FROM B-CELL NON-HODGKINS-LYMPHOMAS

被引:13
作者
KUDOH, S
WANG, Q
HIDALGO, OF
RAYMAN, P
TUBBS, RR
EDINGER, MG
KOLENKO, V
PANUTO, J
BUKOWSKI, R
FINKE, JH
机构
[1] CLEVELAND CLIN FDN,DEPT IMMUNOL,CLEVELAND,OH 44195
[2] CLEVELAND CLIN FDN,DEPT CLIN PATHOL,CLEVELAND,OH 44195
[3] CLEVELAND CLIN FDN,DEPT HEMATOL ONCOL,CLEVELAND,OH 44195
关键词
TCR/CD3; LYMPHOCYTES; CYTOKINES; LYMPHOMAS; SIGNAL TRANSDUCTION;
D O I
10.1007/s002620050216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
T cells infiltrating (T-TIL) B cell non-Hodgkin's lymphomas (NHL) are thought to represent a local host response to the tumor. However, tumor progression in the presence of this T cell infiltrate suggests that the T-TIT, may be functionally impaired. To address this issue we determined whether response to stimulation of T-TIL from 25 patients with NHL through the T cell receptor (TCR/CD3) and the interleukin-2 (IL-2) receptor (IL-2R) was intact, since activation of these receptors is important for proliferation and cytokine production. Our results demonstrate defects in response to stimulation via TCR/CD3 and the IL-2R in T-TIL cells from patients with NHL that were not observed with T cells from the peripheral blood. T-TIL showed minimal proliferation to anti-CD3 and only modest proliferation to IL-2 alone or when combined with anti-CD3. Moreover, cytokine production in T-TIL was impaired since stimulation through the TCR/CD3 complex did not induce mRNA for interferon gamma (IFN gamma), IL-2, IL-4 or IL-10. The functional unresponsiveness of these cells may be linked to altered signalling through the TCR/CD3 since an abnormal tyrosine phosphorylation pattern was detected in T-TIL after stimulation with anti-CD3.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 37 条
[1]  
ALEXANDER JP, 1993, CANCER RES, V53, P1380
[2]   INFLUENCE OF T-HELPER CELL SPECIFIC MONOCLONAL-ANTIBODY ON PROGRESSIVE GROWTH OF B-CELL LYMPHOMAS IN SJL/J MICE - CORRELATION OF ACUTE TREATMENT DOSAGE WITH TUMOR DORMANCY OR COMPLETE REMISSION IN LONG-TERM SURVIVORS [J].
ALISAUSKAS, RM ;
FRIEDMAN, CA ;
PONZIO, NM .
CANCER COMMUNICATIONS, 1990, 2 (01) :33-43
[3]  
Altman A, 1990, Adv Immunol, V48, P227, DOI 10.1016/S0065-2776(08)60756-7
[4]   IMPAIRED CLONOGENIC POTENTIAL OF CD25 POSITIVE T-CELLS IN LYMPH-NODES INVOLVED BY B-CELL NON-HODGKINS-LYMPHOMAS [J].
BONNEFOIX, T ;
CLARET, E ;
PICCINNI, MP ;
JACOB, MC ;
ZHENG, XQ ;
SOTTO, JJ .
IMMUNOLOGY LETTERS, 1991, 27 (02) :135-140
[5]   CYTOLYTIC (TIA-1+) TUMOR INFILTRATING LYMPHOCYTES IN B-CELL NON-HODGKINS-LYMPHOMAS [J].
DIAZ, J ;
TUBBS, R ;
STOLER, M ;
GROGAN, T .
LEUKEMIA & LYMPHOMA, 1993, 9 (1-2) :91-94
[6]  
FINKE JH, 1993, CANCER RES, V53, P5613
[7]   IMPAIRED IN VITRO LYMPHOCYTE TRANSFORMATION IN HODGKINS DISEASE [J].
HERSH, EM ;
OPPENHEIM, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (19) :1006-+
[8]  
ITOH K, 1986, CANCER RES, V46, P3011
[9]  
JACOB MC, 1990, BLOOD, V75, P1154
[10]   INDUCTION OF IMMUNE-RESPONSES IN PATIENTS WITH B-CELL LYMPHOMA AGAINST THE SURFACE-IMMUNOGLOBULIN IDIOTYPE EXPRESSED BY THEIR TUMORS [J].
KWAK, LW ;
CAMPBELL, MJ ;
CZERWINSKI, DK ;
HART, S ;
MILLER, RA ;
LEVY, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) :1209-1215